Anand Bhaskar 4
4 · Summit Therapeutics Inc. · Filed Oct 23, 2025
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-10-21$18.74/sh+26,680$499,983→ 159,751 total
Footnotes (2)
- [F1]Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.
- [F2]Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.